Vaginismus
2
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Biolab Pharma0.20% sodium hyaluronate gel
AbbVieBOTOX
Materna MedicalMilli Vaginal Dilator
Clinical Trials (3)
Total enrollment: 276 patients across 3 trials
Hydration and Acceptability of the Genital and Skin Mucosa of a Vaginal Moisturizer in Menopausal Women
Start: Mar 2025Est. completion: Oct 202545 patients
Phase 3Not Yet Recruiting
Botox Injection for Treatment of Vaginismus
Start: Aug 2010Est. completion: Dec 201231 patients
Phase 1Completed
Prospective on Market Patient-reported Outcomes for Milli
Start: May 2024Est. completion: Dec 2025200 patients
N/AActive Not Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.